Risk of thromboembolism in 14,000 individuals with coeliac disease

Jonas F Ludvigsson1, Adina Welander, Riitta Lassila

  • 1Department of Paediatrics, Orebro University Hospital, and Department of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. jonasludvigsson@yahoo.com

Insights

Individuals with coeliac disease (CD) face an elevated risk of venous thromboembolism (VTE), particularly when diagnosed in adulthood. This association highlights the importance of considering VTE risk in CD patients.

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Hematology

Background:

  • Coeliac disease (CD) is an autoimmune disorder affecting the small intestine.
  • Venous thromboembolism (VTE) is a significant health concern with multifactorial causes.
  • The relationship between CD and VTE risk requires further investigation.

Purpose of the Study:

  • To investigate the association between coeliac disease and the risk of developing subsequent venous thromboembolism.
  • To determine if the risk of VTE differs based on the age of CD diagnosis.

Main Methods:

  • Utilized the Swedish national inpatient register to identify 14,207 individuals with CD (1964-2003).
  • Matched CD patients with 69,048 reference individuals based on age, sex, calendar year, and county.
  • Employed Cox regression analysis to estimate hazard ratios (HRs) for VTE in individuals with over 1 year of follow-up and no prior VTE.

Main Results:

  • Coeliac disease was associated with a significantly increased risk of subsequent VTE (HR = 1.86).
  • The elevated VTE risk was primarily observed in individuals diagnosed with CD in adulthood.
  • The association persisted even when comparing CD patients to general inpatients (adjusted HR = 1.27).

Conclusions:

  • A statistically significant positive association exists between coeliac disease and venous thromboembolism.
  • The increased VTE risk in CD patients may be influenced by factors such as surveillance bias and chronic inflammation.
  • Adult-onset CD diagnosis is a key factor in the heightened VTE risk.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...